Potential cholesterol-lowering drug molecule has prostate cancer fighting capabilities

Posted by on April 14, 2016 9:00 pm
Categories: health

Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Researchers have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of prostate cancer, but also can kill cancerous cells.

Leave a Reply

Your email address will not be published. Required fields are marked *